These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 38795678)
1. Quality of life outcomes comparing primary Transoral Robotic Surgery (TORS) with primary radiotherapy for early-stage oropharyngeal squamous cell carcinoma: A systematic review and meta-analysis. Gupta KK; De M; Athanasiou T; Georgalas C; Garas G Eur J Surg Oncol; 2024 Jul; 50(7):108434. PubMed ID: 38795678 [TBL] [Abstract][Full Text] [Related]
2. Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma. Howard J; Masterson L; Dwivedi RC; Riffat F; Benson R; Jefferies S; Jani P; Tysome JR; Nutting C Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010963. PubMed ID: 27943254 [TBL] [Abstract][Full Text] [Related]
3. Early-stage squamous cell carcinoma of the oropharynx: radiotherapy vs. trans-oral robotic surgery (ORATOR)--study protocol for a randomized phase II trial. Nichols AC; Yoo J; Hammond JA; Fung K; Winquist E; Read N; Venkatesan V; MacNeil SD; Ernst DS; Kuruvilla S; Chen J; Corsten M; Odell M; Eapen L; Theurer J; Doyle PC; Wehrli B; Kwan K; Palma DA BMC Cancer; 2013 Mar; 13():133. PubMed ID: 23514246 [TBL] [Abstract][Full Text] [Related]
4. A Descriptive Study of Quality of Life Following Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma. Diaconescu A; Silver JA; Subramaniam T; Sewitch MJ; Mascarella MA; Ramirez-Garcia Luna J; Golabi N; Richardson K; Bouganim N; Forghani R; Marcin Mlynarek A; Hier MP; Sadeghi N J Otolaryngol Head Neck Surg; 2024; 53():19160216241248670. PubMed ID: 38888957 [TBL] [Abstract][Full Text] [Related]
5. Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial. Nichols AC; Theurer J; Prisman E; Read N; Berthelet E; Tran E; Fung K; de Almeida JR; Bayley A; Goldstein DP; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Winquist E; Hammond JA; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Chen J; Corsten M; Johnson-Obaseki S; Eapen L; Odell M; Parker C; Wehrli B; Kwan K; Palma DA Lancet Oncol; 2019 Oct; 20(10):1349-1359. PubMed ID: 31416685 [TBL] [Abstract][Full Text] [Related]
6. Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial. Nichols AC; Theurer J; Prisman E; Read N; Berthelet E; Tran E; Fung K; de Almeida JR; Bayley A; Goldstein DP; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Winquist E; Hammond JA; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Chen J; Corsten M; Johnson-Obaseki S; Odell M; Parker C; Wehrli B; Kwan K; Palma DA J Clin Oncol; 2022 Mar; 40(8):866-875. PubMed ID: 34995124 [TBL] [Abstract][Full Text] [Related]
7. Oncologic outcomes and patient-reported quality of life in patients with oropharyngeal squamous cell carcinoma treated with definitive transoral robotic surgery versus definitive chemoradiation. Ling DC; Chapman BV; Kim J; Choby GW; Kabolizadeh P; Clump DA; Ferris RL; Kim S; Beriwal S; Heron DE; Duvvuri U Oral Oncol; 2016 Oct; 61():41-6. PubMed ID: 27688103 [TBL] [Abstract][Full Text] [Related]
8. Outcomes of transoral robotic surgery for early-stage oropharyngeal squamous cell carcinoma with low rates of adjuvant therapy: A consecutive single-institution study from 2013 to 2020. Meldgaard Justesen M; Kronberg Jakobsen K; Fenger Carlander AL; Hjordt Holm Larsen M; Wessel I; Kiss K; Friborg J; Ibrahim Channir H; Rubek N; Grønhøj C; von Buchwald C Oral Oncol; 2024 May; 152():106783. PubMed ID: 38569317 [TBL] [Abstract][Full Text] [Related]
9. Making a case for high-volume robotic surgery centers: A cost-effectiveness analysis of transoral robotic surgery. Rudmik L; An W; Livingstone D; Matthews W; Seikaly H; Scrimger R; Marshall D J Surg Oncol; 2015 Aug; 112(2):155-63. PubMed ID: 26171771 [TBL] [Abstract][Full Text] [Related]
10. Survival and Swallowing Function after Primary Radiotherapy versus Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma. Hughes RT; Levine BJ; May N; Shenker RF; Yang JH; Lanier CM; Frizzell BA; Greven KM; Waltonen JD ORL J Otorhinolaryngol Relat Spec; 2023; 85(5):284-293. PubMed ID: 37647863 [TBL] [Abstract][Full Text] [Related]
11. Transoral robotic surgery for oropharyngeal cancer: long-term quality of life and functional outcomes. Dziegielewski PT; Teknos TN; Durmus K; Old M; Agrawal A; Kakarala K; Marcinow A; Ozer E JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1099-108. PubMed ID: 23576186 [TBL] [Abstract][Full Text] [Related]
12. Quality of Life After Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharynx Cancer. Silver JA; Bouganim N; Richardson K; Henry M; Mascarella MA; Ramirez-GarciaLuna J; Golabi N; Mlynarek AM; Zeitouni A; Hier MP; Caglar D; Esfahani K; Sadeghi N JAMA Otolaryngol Head Neck Surg; 2024 Jan; 150(1):65-74. PubMed ID: 38060238 [TBL] [Abstract][Full Text] [Related]
13. Transoral robotic surgery alone for oropharyngeal cancer: quality-of-life outcomes. Choby GW; Kim J; Ling DC; Abberbock S; Mandal R; Kim S; Ferris RL; Duvvuri U JAMA Otolaryngol Head Neck Surg; 2015 Jun; 141(6):499-504. PubMed ID: 25834991 [TBL] [Abstract][Full Text] [Related]
14. De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma. Howard J; Dwivedi RC; Masterson L; Kothari P; Quon H; Holsinger FC Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012939. PubMed ID: 30550641 [TBL] [Abstract][Full Text] [Related]
15. Primary transoral robotic surgery with concurrent neck dissection for early stage oropharyngeal squamous cell carcinoma implemented at a Danish head and neck cancer center: a phase II trial on feasibility and tumour margin status. Rubek N; Channir HI; Charabi BW; Lajer CB; Kiss K; Nielsen HU; Bentzen J; Friborg J; von Buchwald C Eur Arch Otorhinolaryngol; 2017 May; 274(5):2229-2237. PubMed ID: 28050651 [TBL] [Abstract][Full Text] [Related]
16. Treatment of oropharyngeal squamous cell carcinoma: Is swallowing quality better after TORS or RT? Campo F; Iocca O; De Virgilio A; Mazzola F; Mercante G; Pichi B; Holsinger FC; Di Maio P; Ramella S; Pellini R Radiother Oncol; 2023 Jun; 183():109547. PubMed ID: 36813176 [TBL] [Abstract][Full Text] [Related]
17. Long-term quality of life & functional outcomes after treatment of oropharyngeal cancer. Scott SI; Kathrine Ø Madsen A; Rubek N; Charabi BW; Wessel I; Fredslund Hadjú S; Jensen CV; Stephen S; Patterson JM; Friborg J; Hutcheson KA; Kehlet H; von Buchwald C Cancer Med; 2021 Jan; 10(2):483-495. PubMed ID: 33277795 [TBL] [Abstract][Full Text] [Related]
18. The Role of Transoral Robotic Surgery in the Management of HPV Negative Oropharyngeal Squamous Cell Carcinoma. Sload R; Silver N; Jawad BA; Gross ND Curr Oncol Rep; 2016 Sep; 18(9):53. PubMed ID: 27469262 [TBL] [Abstract][Full Text] [Related]
19. Comparison of margins and survival between transoral robotic surgery (TORS) and non-robotic endoscopic surgery for oropharyngeal cancer. Groysman M; Gleadhill C; Baker A; Wang SJ; Bearelly S Am J Otolaryngol; 2023; 44(6):103982. PubMed ID: 37531886 [TBL] [Abstract][Full Text] [Related]
20. Avoidance of primary site adjuvant radiotherapy following transoral robotic surgery: a cohort study. Fradet L; Charters E; Gao K; Froggatt C; Palme C; Riffat F; Nguyen K; Wu R; Milross C; Clark JR ANZ J Surg; 2022 Mar; 92(3):511-517. PubMed ID: 35018703 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]